These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 24496827)

  • 1. Antigenic and genetic characterization of a divergent African virus, Ikoma lyssavirus.
    Horton DL; Banyard AC; Marston DA; Wise E; Selden D; Nunez A; Hicks D; Lembo T; Cleaveland S; Peel AJ; Kuzmin IV; Rupprecht CE; Fooks AR
    J Gen Virol; 2014 May; 95(Pt 5):1025-1032. PubMed ID: 24496827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete genome sequence of Ikoma lyssavirus.
    Marston DA; Ellis RJ; Horton DL; Kuzmin IV; Wise EL; McElhinney LM; Banyard AC; Ngeleja C; Keyyu J; Cleaveland S; Lembo T; Rupprecht CE; Fooks AR
    J Virol; 2012 Sep; 86(18):10242-3. PubMed ID: 22923801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC
    J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utilisation of Chimeric Lyssaviruses to Assess Vaccine Protection against Highly Divergent Lyssaviruses.
    Evans JS; Wu G; Selden D; Buczkowski H; Thorne L; Fooks AR; Banyard AC
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29543715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.
    Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR
    J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ikoma lyssavirus, highly divergent novel lyssavirus in an African civet.
    Marston DA; Horton DL; Ngeleja C; Hampson K; McElhinney LM; Banyard AC; Haydon D; Cleaveland S; Rupprecht CE; Bigambo M; Fooks AR; Lembo T
    Emerg Infect Dis; 2012 Apr; 18(4):664-7. PubMed ID: 22469151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
    Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
    Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Rabies Vaccines Do Not Confer Protective Immunity against Divergent Lyssaviruses Circulating in Europe.
    Echevarría JE; Banyard AC; McElhinney LM; Fooks AR
    Viruses; 2019 Sep; 11(10):. PubMed ID: 31554170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV).
    Calvelage S; Tammiranta N; Nokireki T; Gadd T; Eggerbauer E; Zaeck LM; Potratz M; Wylezich C; Höper D; Müller T; Finke S; Freuling CM
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Taxonomic Characteristics of Matlo and Phala Bat Rabies-Related Lyssaviruses Identified in South Africa.
    Viljoen N; Weyer J; Coertse J; Markotter W
    Viruses; 2023 Oct; 15(10):. PubMed ID: 37896824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of isolations of unusual lyssaviruses (rabies and Mokola virus) identified retrospectively from Zimbabwe.
    Bingham J; Javangwe S; Sabeta CT; Wandeler AI; Nel LH
    J S Afr Vet Assoc; 2001 Jun; 72(2):92-4. PubMed ID: 11513267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing Rabies Vaccine Protection against a Novel Lyssavirus, Kotalahti Bat Lyssavirus.
    Shipley R; Wright E; Lean FZX; Selden D; Horton DL; Fooks AR; Banyard AC
    Viruses; 2021 May; 13(5):. PubMed ID: 34065574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on the genetic, antigenic and pathogenic characteristics of Bokeloh bat lyssavirus.
    Nolden T; Banyard AC; Finke S; Fooks AR; Hanke D; Höper D; Horton DL; Mettenleiter TC; Müller T; Teifke JP; Freuling CM
    J Gen Virol; 2014 Aug; 95(Pt 8):1647-1653. PubMed ID: 24828330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and Characterization of Cross-Reactive Human Monoclonal Antibodies That Potently Neutralize Australian Bat Lyssavirus Variants and Other Phylogroup 1 Lyssaviruses.
    Weir DL; Coggins SA; Vu BK; Coertse J; Yan L; Smith IL; Laing ED; Markotter W; Broder CC; Schaefer BC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33804519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel lyssaviruses isolated from bats in Russia.
    Botvinkin AD; Poleschuk EM; Kuzmin IV; Borisova TI; Gazaryan SV; Yager P; Rupprecht CE
    Emerg Infect Dis; 2003 Dec; 9(12):1623-5. PubMed ID: 14720408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serological Survey of Lyssaviruses in Polish Bats in the Frame of Passive Rabies Surveillance Using an Enzyme-Linked Immunosorbent Assay.
    Orłowska A; Smreczak M; Freuling CM; Müller T; Trębas P; Rola J
    Viruses; 2020 Feb; 12(3):. PubMed ID: 32121200
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel lyssavirus in bat, Spain.
    Aréchiga Ceballos N; Vázquez Morón S; Berciano JM; Nicolás O; Aznar López C; Juste J; Rodríguez Nevado C; Aguilar Setién A; Echevarría JE
    Emerg Infect Dis; 2013 May; 19(5):793-5. PubMed ID: 23648051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel lyssavirus in Natterer's bat, Germany.
    Freuling CM; Beer M; Conraths FJ; Finke S; Hoffmann B; Keller B; Kliemt J; Mettenleiter TC; Mühlbach E; Teifke JP; Wohlsein P; Müller T
    Emerg Infect Dis; 2011 Aug; 17(8):1519-22. PubMed ID: 21801640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus.
    Shipley R; Wright E; Smith SP; Selden D; Fooks AR; Banyard AC
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Lyssavirus glycoprotein: A key to cross-immunity.
    Buthelezi SG; Dirr HW; Chakauya E; Chikwamba R; Martens L; Tsekoa TL; Stoychev SH; Vandermarliere E
    Virology; 2016 Nov; 498():250-256. PubMed ID: 27614701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.